localized reaction to tirzepatide Severe injection Tirzepatide big red hive at

Victoza (liraglutide) Approved uses: Adults and children over 10 with type 2 diabetes, and adults with type 2 diabetes and heart disease Drug type: Once-daily injection Doses: 0.6 mg (initial dose), 1.2 mg, and 1.8 mg Cost: Victoza is covered by most health plans, including Medicare and Medicaid

Moreover, because patients with T1D were excluded from studies looking at cardiovascular and renal outcomes with the use of GLP-1RA, it remains unknown whether those benefits observed in patients with T2D or obesity without T2D translate to the T1D population

These are study questions, not product claims

It remains an experimental compound not an approved or licensed medicine and is supplied here strictly for laboratory and research use

Drinking plenty of water and staying hydrated may also help reduce discomfort from gastrointestinal symptoms